RELEASED ON 29/01/13 (DD/MM/YY)
Chongqing Fuan Pharmaceutical (Group) is engaged in the manufacturing, research, and sale of active pharmaceutical ingredients (API) and formulations. Its products include penicillin, cephalosporin , and other intermediates. The company primarily operates in China, where it is headquartered in Chongqing.
The company recorded revenues of CNY358.5 million (approximately $55.6 million) in the fiscal year ended December 2011. Its net profit was CNY95.2 million (approximately $14.8 million) in fiscal 2011.
SOURCE MarketLine
Chongqing Fuan Pharmaceutical (Group) is engaged in the manufacturing, research, and sale of active pharmaceutical ingredients (API) and formulations. Its products include penicillin, cephalosporin , and other intermediates. The company primarily operates in China, where it is headquartered in Chongqing.
The company recorded revenues of CNY358.5 million (approximately $55.6 million) in the fiscal year ended December 2011. Its net profit was CNY95.2 million (approximately $14.8 million) in fiscal 2011.
SOURCE MarketLine